SCHEMBL6020523

SCHEMBL6020523

CCN(C#N)C(=O)C(Cc1ccc2ccccc2c1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
F2 P00734 7/20 0.52
CTSS P25774 4/20 0.46
CTSB P07858 3/20 0.46
CTSL P07711 3/20 0.46
CTSK P43235 3/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
F10 P00742 1/20 0.44
PLG P00747 1/20 0.44
PLAT P00750 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019514 0.92 F2 (0.51) F2F10PLGPLATPRSS1
SCHEMBL6020574 0.91 MMP13 (0.51) F2ITGB3ITGA2BPRSS1MMP9
SCHEMBL6020208 0.91 ALDH1A1 (0.53) F2CTSSCTSBCTSKF10
SCHEMBL6020123 0.88 CTSL (0.55) CTSSCTSBCTSLCTSKMMP9
SCHEMBL6019573 0.88 F2 (0.47) F2CTSSCTSBCTSLCTSK
SCHEMBL6020830 0.86 MEN1 (0.51) F2CTSSCTSBCTSLCTSK
SCHEMBL6021322 0.86 F2 (0.51) F2F10PLGPLATPRSS1
SCHEMBL6019978 0.85 MAPT (0.47) F2CTSSCTSBCTSLCTSK
SCHEMBL6021205 0.84 MMP9 (0.53) CTSSCTSBCTSLCTSKMMP9
SCHEMBL6020743 0.82 MMP9 (0.53) CTSSCTSBCTSLCTSKMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP claimed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO claimed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP disclosed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO disclosed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 F2 4703/4885CTSS 2720/4885CTSB 2514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.